Ocuphire Pharma Inc (OCUP)
1.68
-0.06
(-3.17%)
USD |
NASDAQ |
May 17, 16:00
1.68
0.00 (0.00%)
After-Hours: 20:00
Ocuphire Pharma Total Liabilities (Quarterly): 5.787M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.787M |
| December 31, 2023 | 4.042M |
| September 30, 2023 | 3.909M |
| June 30, 2023 | 5.761M |
| March 31, 2023 | 4.154M |
| December 31, 2022 | 2.753M |
| September 30, 2022 | 2.691M |
| Date | Value |
|---|---|
| June 30, 2022 | 3.304M |
| March 31, 2022 | 3.213M |
| December 31, 2021 | 3.855M |
| September 30, 2021 | 2.638M |
| June 30, 2021 | 2.699M |
| March 31, 2021 | 2.31M |
| December 31, 2020 | 31.15M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.31M
Minimum
Mar 2021
31.15M
Maximum
Dec 2020
5.590M
Average
3.580M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.84M |
| Shareholders Equity (Quarterly) | 46.06M |
| Current Ratio | 8.959 |